Follow the Physiomics plc share price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares are listed on the UK market, under the supervision of RNS (LSE). Market capitalisation: €2.3m. The latest transaction was reported on 14 July 2026 (Purchase). Among the most active insiders: Ian Bagnall. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Physiomics plc es una empresa de biotecnología centrada en el desarrollo de soluciones de modelado para el tratamiento del cáncer. Utiliza tecnologías avanzadas para optimizar terapias y mejorar los resultados clínicos.